期刊
CLINICAL CANCER RESEARCH
卷 19, 期 7, 页码 1631-1633出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-13-0051
关键词
-
类别
资金
- NINDS NIH HHS [R01 NS059876, R01NS078402, R01 NS078402, R01NS059876] Funding Source: Medline
In glioblastoma cells the receptor tyrosine kinase c-Met is upregulated in response to bevacizumab and plays an important role in promoting invasion and tumor recurrence. These data support novel links between VEGF-A and hepatocyte growth factor and suggest that c-Met and its signaling effectors may be effective targets for anti-invasive therapies. Clin Cancer Res; 19(7); 1631-3. (C) 2013 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据